VINZENZ GRUPPE
     
 

I-131 as adjuvant treatment for differentiated thyroid carcinoma may cause an increase in the incidence of secondary haematological malignancies: an "inconvenient" truth?

Verburg, Frederik A., Giovanella, Luca, Iakovou, Ioannis, Konijnenberg, Mark W., Langsteger, Werner, Lassmann, Michael, Mihailovic, Jasna und Luster, Markus (2018) I-131 as adjuvant treatment for differentiated thyroid carcinoma may cause an increase in the incidence of secondary haematological malignancies: an "inconvenient" truth? European Journal of Nuclear Medicine and Molecular Imaging, 45 (13). pp. 2247-2249.

[img] Text (I-131 as adjuvant treatment for differentiated thyroid carcinoma may cause an increase in the incidence of secondary haematological malignancies: an "inconvenient" truth?)
2018 EJNMMI Langsteger.pdf
Restricted to Nur registrierte Benutzer

Download (340kB)
Typ des Eintrags: Fachpublikation (peer reviewed)
Bereiche: Ordensklinikum Linz Barmherzige Schwestern > Nuklearmedizin
Benutzer: Prof. Werner Langsteger
Hinterlegungsdatum: 19 Mär 2019 11:42
Letzte Änderung: 19 Mär 2019 11:42
URI: http://eprints.vinzenzgruppe.at/id/eprint/8523

Actions (login required)

Eintrag anzeigen Eintrag anzeigen